Patents by Inventor Lakkireddy Pullareddy

Lakkireddy Pullareddy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the preparation of sphingosine 1-phosphate receptor modulators and solid forme thereof
    Patent number: 12703681
    Abstract: The present invention relates to process for preparation of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxy imino]ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, intermediates, salts and solid forms thereof to pharmaceutical compositions comprising the salts and solid forms and to use of said compositions for the treatment of multiple sclerosis, particularly secondary progressive multiple sclerosis.
    Type: Grant
    Filed: May 27, 2021
    Date of Patent: August 11, 2026
    Assignee: CIPLA LIMITED
    Inventors: Srinivas Laxminarayan Pathi, Puppala Ravi Kumar, Ramanaiah Chennuru, Durga Surya Narayana Yarra, Yellanki Jagannadham, Siva Krishna Nangedda, Lakkireddy Pullareddy, Raju Barla
  • SOLID STATE FORMS OF RELUGOLIX
    Publication number: 20240287090
    Abstract: The present invention relates to solid state forms of Gonadotropin-Releasing Hormone Receptor (GnRH) antagonist of Formula (I) and a pharmaceutically acceptable salt thereof, namely 1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy pyridazin-3-yl-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea, and its pharmaceutically acceptable salts thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use.
    Type: Application
    Filed: August 17, 2022
    Publication date: August 29, 2024
    Inventors: Arijit DAS, Ramanaiah CHENNURU, Anjaneyaraju INDUKURI, Lakkireddy PULLAREDDY, Pyla Kranthi TEJA
  • METHODS FOR THE PREPARATION OF SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS AND SOLID FORME THEREOF
    Publication number: 20230212115
    Abstract: The present invention relates to process for preparation of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxy imino]ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, intermediates, salts and solid forms thereof to pharmaceutical compositions comprising the salts and solid forms and to use of said compositions for the treatment of multiple sclerosis, particularly secondary progressive multiple sclerosis.
    Type: Application
    Filed: May 27, 2021
    Publication date: July 6, 2023
    Inventors: Srinivas Laxminarayan Pathi, Puppala Ravi Kumar, Ramanaiah Chennuru, Durga Surya Narayana YARRA, Yellanki Jagannadham, Siva Krishna Nangedda, Lakkireddy Pullareddy, Raju Barla